News

Analyzing the Impact of EV Tax Credits on Tesla and Rivian

Analyzing the Impact of EV Tax Credits on Tesla and Rivian

Tesla and Rivian Deliveries Surpass Expectations

Tesla Inc (NASDAQ: TSLA) and Rivian Automotive (NASDAQ: RIVN) have recently reported third-quarter vehicle deliveries that exceed market consensus. This has sparked optimism among investors and analysts alike, despite upcoming challenges tied to the EV tax credit expiration.

Significant Deliveries Amid Anticipated Changes

Tesla's third-quarter deliveries reached approximately 497,000 units, reflecting a 7% increase compared to the previous year. This figure was notably higher than Goldman Sachs’ estimated 455,000 vehicles, showcasing Tesla's strong demand and operational efficiency.

On the other hand, Rivian reported a remarkable increase in its deliveries as well. Deliveries for the quarter totaled 13,200 units, which is a 32% year-over-year rise, surpassing analyst expectations of 12,700 vehicles, although it fell short of Goldman Sachs’ estimate of 13,950 units.

The Upcoming Tax Credit Expiration and Its Effects

The impending expiration of the federal EV tax credit has led analysts to assess its potential impact on the automotive industry. Mark Delaney, a Goldman Sachs analyst, noted that the U.S. EV sector may have benefited from an influx of orders before the credits ceased on September 30. Customers who secured a purchase order and deposit prior to this date may still receive the credit, implying potential benefits extending into the fourth quarter.

Despite the short-term advantages, projections are made regarding the inevitable slowdown in sales as the federal tax credit becomes unavailable. Delaney anticipates that this scenario could create a double-digit percent headwind for the sector moving forward.

New Model Launches as a Response

In response to the changing landscape, companies like Tesla are expected to focus on their product launches as a primary strategy to counteract the loss of the tax incentives. Tesla is gearing up with exciting new models, including the lower-cost options and the Model Y L, to capture customer interest and demand.

Rivian, likewise, is looking ahead to its upcoming R2 launch, which is anticipated to play an essential role in maintaining its sales momentum amidst the loss of federal credits. This emphasis on new product launches could become critical in sustaining consumer interest in EVs.

Updated Price Target for Tesla

Goldman Sachs recently maintained a Neutral rating for Tesla while raising its price target from $395 to $425 in light of the company’s strong delivery figures. Analysts attribute this increase to a robust performance in the U.S. market, with a surge in sales likely driven by last-minute purchases before the end of the EV purchase credit.

Furthermore, Delaney highlights that Tesla's U.S. sales have seen over a 10% rise year-over-year. While sales in Europe and China faced declines compared to last year, Delaney did note an uptick quarter-over-quarter, indicating some recovery in those regions.

Future Catalysts for Tesla

Looking towards the fourth quarter and beyond, Delaney points out that several factors could serve as potential catalysts for Tesla's future performance. The upcoming shareholder meeting scheduled for November 6 and the release of third-quarter earnings will be significant events to monitor as they may positively influence stock performance.

Further, key talking points around Tesla include expectations for vehicle deliveries, profitability margins, and advancements in projects like robotaxis and Full Self-Driving technology, coupled with growth avenues in Tesla Energy and other sectors.

Rivian Reassesses Guidance

In parallel with Tesla's developments, Rivian has slightly adjusted its full-year delivery expectations. The company now anticipates delivering 42,500 vehicles, which aligns with Goldman Sachs' estimates while being marginally above consensus projections. Delaney maintained a Neutral rating with a price target of $15 for Rivian following the recent delivery announcements.

Key performance indicators to watch for Rivian include increasing production volumes, maintaining healthy margins, achieving vertical integration, and managing cash flow effectively amid supply chain challenges.

Current Stock Performance

As of the latest trading sessions, Tesla's stock saw a 2.2% decrease, settling at $426.45, reflecting the broader market’s reactions to the shifting EV landscape. The stock has experienced a range between $212.11 to $488.54 over the past year, with a positive year-to-date gain of 12.4%.

Similarly, Rivian’s stock decreased by 0.7%, with a current price of $13.44. Over the year, Rivian's stock has fluctuated between $9.50 and $17.14, marking a modest gain of 1.4% thus far in 2025.

Frequently Asked Questions

What is the significance of the EV tax credit expiration?

The expiration can negatively impact EV sales, creating challenges for companies like Tesla and Rivian in maintaining delivery levels in the following quarters.

How did Tesla and Rivian perform in the last quarter?

Both companies exceeded delivery expectations, with Tesla delivering approximately 497,000 units and Rivian reporting 13,200 deliveries.

What are the future outlooks for Tesla?

Future outlook includes monitoring vehicle deliveries, vehicle margins, and new model launches, which are expected to become key growth drivers.

What adjustments has Rivian made to its delivery guidance?

Rivian has lowered its full-year delivery guidance slightly by 500 vehicles, bringing its midpoint estimate to 42,500 vehicles.

How are the stocks of Tesla and Rivian performing currently?

Tesla's stock is down 2.2% to $426.45, while Rivian's is down 0.7% to $13.44 amidst changing market sentiments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

DoorLoop Achieves Prestigious Award for User Satisfaction

Updated Category News Views 227

DoorLoop Achieves Notable Recognition in Property Management Software Celebrated on Capterra's 2025 Shortlist with Outstanding Satisfaction Ratings DoorLoop, the innovative property management software designed for efficiency, has received the honor of being the highest-rated choice among property management software in the latest Capterra selection. This recognition from...

Continue Reading
The Surprising Rise of Robocalls: What We Can Do About It

Updated Category News Views 530

The Robocall Epidemic of 2025 In a startling revelation, U.S. consumers experienced over 4.3 billion robocalls just in July 2025. This staggering statistic, reported by YouMail's Robocall Index, shines a light on the growing nuisance that has plagued phone users for years. Interestingly, while July's figures remained consistent with the previous year, there has been a...

Continue Reading
Revolutionizing Telecommunications: The Launch of 5-Band RRU

Updated Category News Views 197

ZTE and MTN’s Groundbreaking Collaboration for Telecom Innovation ZTE Corporation and MTN have announced the successful commercial deployment of an innovative technology—the world's first 5-band Remote Radio Unit (RRU). This significant achievement highlights a new era in telecommunications, with implications that stretch beyond individual companies to impact the...

Continue Reading
Innovative Hydro Project Set to Transform Energy Landscape

Updated Category News Views 167

Introducing a Revolutionary Hydroelectric Project In a significant move towards advancing renewable energy, Current Hydro has announced the launch of its 28.5 MW Robert C. Byrd Locks and Dam Hydroelectric Project. This project will utilize the flows of the Ohio River, providing reliable and sustainable energy solutions while also focusing on environmental preservation and...

Continue Reading
Mercury Systems Secures Defense Contract to Enhance RF Solutions

Updated Category News Views 213

Mercury Systems Wins Key Defense Contract Mercury Systems, Inc. (NASDAQ: MRCY) is making headlines as it has been selected by the U.S. Department of Defense (DoD) for an important contract that seeks to bolster America’s defense supply chain. The focus centers around the development of a state-of-the-art RF signal conditioning multi-chip package (MCP), which is pivotal...

Continue Reading